ERVW-1 and neoplasm: This Env protein has attracted interest as a potential Tumour-Associated Antigen (TAA) because it is expressed in multiple tumour types but not healthy tissues [6] (except in the placenta [7]), and thus might offer a target for a broad-spectrum anti-cancer immunotherapy.